Drug Shortage Report for SANDOZ DILTIAZEM T

Last updated on 2020-04-01 History
Report ID 14879
Drug Identification Number 02245922
Brand name SANDOZ DILTIAZEM T
Common or Proper name DILTIAZEM
Company Name SANDOZ CANADA INCORPORATED
Market Status CANCELLED PRE MARKET
Active Ingredient(s) DILTIAZEM HYDROCHLORIDE
Strength(s) 360MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL
Packaging size 100
ATC code C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2017-07-03
Estimated end date Unknown
Actual end date 2019-09-28
Shortage status Resolved
Updated date 2020-04-01
Company comments Stock available at some wholesalers/Inventaire disponible chez certains grossistes
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2020-04-01 French Compare
v15 2020-04-01 English Compare
v14 2018-07-03 French Compare
v13 2018-07-03 English Compare
v12 2018-02-05 French Compare
v11 2018-02-05 English Compare
v10 2018-01-08 French Compare
v9 2018-01-08 English Compare
v8 2017-11-13 French Compare
v7 2017-11-13 English Compare
v6 2017-09-06 French Compare
v5 2017-09-06 English Compare
v4 2017-07-06 French Compare
v3 2017-07-06 English Compare
v2 2017-07-06 French Compare
v1 2017-07-06 English Compare

Showing 1 to 16 of 16